Financhill
Back

Akero Therapeutics Quote, Financials, Valuation and Earnings

Akero Therapeutics Price Quote

$25.24
+0.01 (+3.1%)
(Updated: March 29, 2024 at 6:25 AM ET)

Akero Therapeutics Key Stats

Buy
57
Akero Therapeutics (AKRO) is a Buy

Day range:
$23.71 - $25.43
52-week range:
$11.25 - $58.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.25%

Volume:
593.2K
Avg. volume:
1.9M
1-year change:
-34.16%
Market cap:
$1.7B
Revenue:
$0
EPS:
$-2.88

How Much Does Akero Therapeutics Make?

Data Unavailable

Is Akero Therapeutics Growing As A Company?

Data Unavailable

Akero Therapeutics Stock Price Performance

What Is Akero Therapeutics 52-Week High & Low?

Akero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akero Therapeutics?

Is Akero Therapeutics Cash Flow Positive?

  • What Is AKRO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$145.4M
  • What Is Akero Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $353.3M
  • What Is Akero Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$223.6M

Akero Therapeutics Return On Invested Capital

Data Unavailable

Akero Therapeutics Earnings Date & Stock Price

Akero Therapeutics Competitors

  • Who Are Akero Therapeutics's Competitors?
    Below is a list of companies who compete with Akero Therapeutics or are related in some way:
    • 89bio Inc (ETNB)
    • Ionis Pharmaceuticals Inc (IONS)
    • Eli Lilly and Co (LLY)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • Viking Therapeutics Inc (VKTX)

Akero Therapeutics Dividend Yield

Data Unavailable

Akero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -19.56%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 51.25
Upside from Last Price: 103.13%

Major Shareholders

  • How many AKRO shares are owned by institutional investors?
    87.2M AKRO shares are owned by institutional investors
  • How many AKRO shares are owned by insiders?
    1.2M AKRO shares are owned by insiders